|
|
SFX by Ex Libris Inc.
|
List of services to meet your request
|
||||||||||||
|
||||||||||||
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
![](https://beacon01.alma.exlibrisgroup.com/boom/apache_pb.gif?SRVR=adz.izum.si&IP=193.2.126.232&A=SFX&P=SFXMenu&S=s9E9E1716-59F5-11EF-B057-D4E684CE164B&I=39IZM&T=&OP=Display&O=html&O1=15067376&O2=991042752810054&O3=&O4=summon.serialssolutions.com&O5=https%3A%2F%2Fadz.izum.si%2Fsfxlcl41%3Fctx_enc%3Dinfo%253Aofi%252Fenc%253AUTF-8%26ctx_ver%3DZ39.88-2004%26rfr_id%3Dinfo%253Asid%252Fsummon.serialssolutions.com%26rft.atitle%3DIpilimumab%252FNivolumab-related%2520Opsoclonus-Myoclonus-Ataxia%2520Syndrome%2520Variant%2520in%2520a%2520Patient%2520with%2520Malignant%2520Pleural%2520Mesothelioma%26rft.au%3DMaller%252C%2520Bradley%26rft.au%3DPeguero%252C%2520Edwin%26rft.au%3DTanvetyanon%252C%2520Tawee%26rft.date%3D2018-11-01%26rft.eissn%3D1537-4513%26rft.epage%3D412%26rft.externalDBID%3Dn%252Fa%26rft.externalDocID%3D10_1097_CJI_0000000000000228%26rft.genre%3Darticle%26rft.issn%3D1524-9557%26rft.issue%3D9%26rft.jtitle%3DJournal%2520of%2520immunotherapy%2520%25281997%2529%26rft.spage%3D411%26rft.volume%3D41%26rft_id%3Dinfo%253Adoi%252F10.1097%252FCJI.0000000000000228%26rft_val_fmt%3Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal&O6=1-JOURNALS_AT_OVID_LWW_PROPRIETARY_COLLECTION_EMERGING_MARKET-getFullTxt-object,2-JOURNALS_AT_OVID_LWW_HIGH_IMPACT_COLLECTION_2023_LEGACY_LHIM_23_LGC-getFullTxt-object,3-DOI-getDOI-object,4-COBIB_SI_LCL-getHolding-object,5-ELSEVIER_SCOPUS_FIS_LCL-getAbstract-object,6-ISI_JOURNAL_CITATION_REPORTS_SCIENCE_EDITION-getCitedJournal-object,7-REFWORKS_EXPORT_TOOL-getReference-object,8-SHERPA_RoMEO_LCL-getWebService-object,9-GOOGLE_SCHOLAR_FREE-getWebSearch-object,10-WWW_SEARCH_ENGINES_FREE-getWebSearch-object&O7=1.160903&O8=N&O9=<ctx:context-object identifier="urn:sfxstat:15067376-s9E9E1716-59F5-11EF-B057-D4E684CE164B" timestamp="2024-08-14T06:28:14Z" xmlns:ctx="info:ofi/fmt:xml:xsd:ctx">
<ctx:referent>
<ctx:identifier>urn:sfxid:991042752810054</ctx:identifier>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:journal</ctx:format>
<ctx:metadata>
<jnl:journal xmlns:jnl="info:ofi/fmt:xml:xsd:journal">
<jnl:atitle>Ipilimumab/Nivolumab-related Opsoclonus-Myoclonus-Ataxia Syndrome Variant in a Patient with Malignant Pleural Mesothelioma</jnl:atitle>
<jnl:jtitle>Journal of Immunotherapy</jnl:jtitle>
<jnl:date>2018-11-00</jnl:date>
<jnl:spage>411</jnl:spage>
<jnl:epage>412</jnl:epage>
<jnl:issn>1524-9557</jnl:issn>
<jnl:volume>41</jnl:volume>
<jnl:issue>9</jnl:issue>
<jnl:genre>article</jnl:genre>
<jnl:eissn>1537-4513</jnl:eissn>
<jnl:language>eng</jnl:language>
<jnl:authors></jnl:authors>
</jnl:journal>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:referent>
<ctx:requester>
<ctx:identifier>urn:ip:bf296df09337143d18f18d991323550b3f74bcd0</ctx:identifier>
<ctx:identifier>urn:UUID:s9E9E1716-59F5-11EF-B057-D4E684CE164B</ctx:identifier>
</ctx:requester>
<ctx:referrer>
<ctx:identifier>info:sid/summon.serialssolutions.com</ctx:identifier>
</ctx:referrer>
<ctx:service-type>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:svcList</ctx:format>
<ctx:metadata>
<svc:svcList xmlns:svc="http://www.exlibrisgroup.com/schema/info:ofi/fmt:xml:xsd:sch_svc"></svc:svcList>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:service-type>
<ctx:resolver>
<ctx:identifier>https://adz.izum.si/sfxlcl41</ctx:identifier>
</ctx:resolver>
</ctx:context-object>
&)